ReviR Therapeutics lands $30m Series A

Lapam Capital led the round with participation from other backers that included CDH Investments, 5Y Capital, and Yael Capital.

26 July 2024•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.